Skip to main content
. 2020 Nov 23;71(5):1061–1069. doi: 10.1007/s12031-020-01728-z

Table 2.

Clinical characteristics of the patients group and the control group

Variables Controls, n = 302 Patients with IS, n = 310 P value
Age, year (mean ± SD) 62.2 ± 11.8 62.0 ± 11.3 0.68
Male/female 187 /115 210 /100 0.13
Smoking, yes/no 88/214 109/201 0.11
TC, mmol/L 4.62 ± 1.17 4.88 ± 0.94 0.001
TG, mmol/L 1.44 ± 1.37 1.82 ± 1.58 < 0.001
HDL-C, mmol/L 2.11 ± 10.45 1.13 ± 0.32 < 0.001
Apo-A1,g/L 1.76 ± 1.13 1.23 ± 0.26 < 0.001
Apo-B, g/L 0.75 ± 0.31 1.00 ± 0.31 < 0.001
Hcy, umol/L 13.6 ± 3.91 15.0 ± 3.84 < 0.001
NEFA, mmol/L 0.53 ± 0.28 0.71 ± 0.32 < 0.001

IS, ischemic stroke; SD, standard deviation; TG, triglycerides, HDL, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; Apo-A1, apolipsprotein A1; Apo-B, apolipoprotein B; Hcy, homocysteic acid; NEFA, non-esterified fatty acid